2 results
Approved WMOCompleted
Primary:* To assess the safety and tolerability of LAM-001 administered daily by dry powder inhaler (DPI) for 14 days in patients with lymphangioleiomyomatosis (LAM) (Period 1).* To assess the longer-term safety and tolerability of LAM-001…
Approved WMORecruiting
The objective of this study is to determine the performance, as defined by sensitivity and specificity, of the commercially available Apple Watch-based electrocardiographic registration to identify AF during tachycardia, validated against the gold…